PrecisionLife is attending and presenting new data at AAIC, the largest and most influential international conference on dementia science.
Senior Disease Biologist Andy Malinowski, and Senior Portfolio Manager Krystyna Taylor, will present Alzheimer's Disease Stratification Biomarkers and Cross-Disease Mechanisms on 18 July from 8am onwards - poster number P3-235.
Contact us to learn more about our mechanistic patient stratification insights and how we're identifying more effective therapeutic strategies that are more likely to demonstrate benefit in trials and the clinic in Alzheimer's and 50 other complex chronic diseases.
Stratifying patient subgroups to reduce the risk of future clinical trial failure.